Founded by leading researchers and backed by world-renowned KOLs, ST Diagnostics is transforming cancer treatment monitoring and early resistance detection through its patented, real-time pan-malignancy, dynamic and functional test.  
By bypassing the need for complex NGS or specialized hardware, our pan-malignancy platform integrates seamlessly into routine lab equipment, offering an exceptionally scalable and cost-effective solution for healthcare providers. 

Clinically validated in Aggressive Lymphoma - with POC stages in Lung, Colon and Prostate cancers - we are rapidly expanding into additional high-resistance indications.

Through a lean, licensable assay model, ST Diagnostics removes the barriers of Inventory and infrastructure, aiming to ultimately establish a new standard for periodic screening, ensuring that life-saving early detection is accessible to every patient, everywhere.

Join us in changing cancer outcomes!

ST Innovative Diagnostics Ltd.

Org chart

Teams

Offices